NDC properties for "lenalidomide 10 MG Oral Capsule" (RxCUI 602910)
About this data
The tables show NDC propoerties for lenalidomide 10 MG Oral Capsule with the RxCUI 602910
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for lenalidomide 10 MG Oral Capsule (RxCUI 602910)
| ANDA | ANDA201452 |
|---|---|
| ANDA | ANDA209348 |
| ANDA | ANDA210154 |
| ANDA | ANDA210435 |
| ANDA | ANDA210480 |
| ANDA | ANDA211022 |
| ANDA | ANDA211846 |
| ANDA | ANDA212414 |
| ANDA | ANDA213885 |
| ANDA | ANDA213912 |
| MMSL_CODE | BD15734 |
| MMSL_CODE | CD15734 |
| RxCUI | 602910 |
| SNOMEDCT | 420966002 |
| SPL_SET_ID | 1b2716cf-24b4-4157-a218-58ede63917bd |
| SPL_SET_ID | 51bfdd53-8fd9-4f86-bebe-75de29e6379d |
| SPL_SET_ID | 682e8a86-9f49-45db-a2ea-403ee1dc62d2 |
| SPL_SET_ID | 76f6c1e7-985b-43d9-892c-849df50ae80e |
| SPL_SET_ID | 84d9dec7-9250-4dbd-9a0d-23e75f111892 |
| SPL_SET_ID | 9943e098-20b0-dbb3-af12-7816eedd3f70 |
| SPL_SET_ID | adee5af1-c9ab-c0c7-e400-dea7d2a0d4be |
| SPL_SET_ID | ba2a07fd-ca60-40bc-b79b-9caf81900fa3 |
| SPL_SET_ID | c98fb504-76d0-4c25-9c0b-412885828a7a |
| SPL_SET_ID | ca8cc2cc-c856-e676-4f60-1e46d7b53d73 |
| SPL_SET_ID | f27092f3-3977-4f4a-b214-45309e136e46 |
| SPL_SET_ID | fd23328f-b019-4c14-80d9-4ebd997f26b2 |
| VUID | 4025112 |
| Prescribable Synonym | lenalidomide 10 MG Oral Capsule |
| RXNAV_STR | lenalidomide 10 MG Oral Capsule |
| RxNorm Name | lenalidomide 10 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 602910) |
NDC Properties
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |
NDC Item 00378193701
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-01 |
| NDC Item | 00378193701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00378193728
| NDC 9 | 0378-1937 |
|---|---|
| NDC 10 | 0378-1937-28 |
| NDC Item | 00378193728 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1937-28) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),GRAY(light gray opaque) |
| Color | C48329;C48324 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;10 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1937 |
NDC Item 00480124328
| NDC 9 | 0480-1243 |
|---|---|
| NDC 10 | 0480-1243-28 |
| NDC Item | 00480124328 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0480-1243-28) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 644159 |
| Imprint code | NAT;10mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1243 |
NDC Item 31722025901
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-01 |
| NDC Item | 31722025901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-259-01) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 31722025928
| NDC 9 | 31722-259 |
|---|---|
| NDC 10 | 31722-259-28 |
| NDC Item | 31722025928 |
| Packaging | 28 CAPSULE in 1 BOTTLE (31722-259-28) |
| ANDA | ANDA212414 |
| COLORTEXT | orange,white |
| Color | C48331;C48325 __ |
| FDA SPL set id | 718892 |
| Imprint code | H;L4 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-259 |
NDC Item 43598051201
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-01 |
| NDC Item | 43598051201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-512-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 43598051263
| NDC 9 | 43598-512 |
|---|---|
| NDC 10 | 43598-512-63 |
| NDC Item | 43598051263 |
| Packaging | 28 CAPSULE in 1 BOTTLE (43598-512-63) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap and body) |
| Color | C48330 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;10;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 43598-512 |
NDC Item 47781048501
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-01 |
| NDC Item | 47781048501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-485-01) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 47781048528
| NDC 9 | 47781-485 |
|---|---|
| NDC 10 | 47781-485-28 |
| NDC Item | 47781048528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (47781-485-28) |
| ANDA | ANDA210480 |
| COLORTEXT | YELLOW(GOLD),GRAY |
| Color | C48330;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;639 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-485 |
NDC Item 59651034401
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-01 |
| NDC Item | 59651034401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-344-01) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034407
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-07 |
| NDC Item | 59651034407 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-344-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 59651034428
| NDC 9 | 59651-344 |
|---|---|
| NDC 10 | 59651-344-28 |
| NDC Item | 59651034428 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59651-344-28) |
| ANDA | ANDA213885 |
| COLORTEXT | GREEN(Olive Green Opaque Cap),ORANGE(Orange Opaque Body) |
| Color | C48329;C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;10 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-344 |
NDC Item 60505453401
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-1 |
| NDC Item | 60505453401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4534-1) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 60505453402
| NDC 9 | 60505-4534 |
|---|---|
| NDC 10 | 60505-4534-2 |
| NDC Item | 60505453402 |
| Packaging | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(Blue green opaque),WHITE(Ivory opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 707296 |
| Imprint code | APO;L10 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60505-4534 |
NDC Item 63304004301
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-01 |
| NDC Item | 63304004301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-043-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 63304004327
| NDC 9 | 63304-043 |
|---|---|
| NDC 10 | 63304-043-27 |
| NDC Item | 63304004327 |
| Packaging | 28 CAPSULE in 1 BOTTLE (63304-043-27) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;80 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-043 |
NDC Item 69097038273
| NDC 9 | 69097-382 |
|---|---|
| NDC 10 | 69097-382-73 |
| NDC Item | 69097038273 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-382-73) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 698711 |
| Imprint code | Cipla10mg;382 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 69097-382 |
NDC Item 70710103201
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-1 |
| NDC Item | 70710103201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1032-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70710103207
| NDC 9 | 70710-1032 |
|---|---|
| NDC 10 | 70710-1032-7 |
| NDC Item | 70710103207 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70710-1032-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1032 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70710-1032 |
NDC Item 70771167801
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-1 |
| NDC Item | 70771167801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1678-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 70771167807
| NDC 9 | 70771-1678 |
|---|---|
| NDC 10 | 70771-1678-7 |
| NDC Item | 70771167807 |
| Packaging | 28 CAPSULE in 1 BOTTLE (70771-1678-7) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Turquoise blue opaque body) |
| Color | C48325;C48333 __ |
| FDA SPL set id | 731991 |
| Imprint code | 1032 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 70771-1678 |
NDC Item 76282069848
| NDC 9 | 76282-698 |
|---|---|
| NDC 10 | 76282-698-48 |
| NDC Item | 76282069848 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (76282-698-48) |
| ANDA | ANDA210435 |
| COLORTEXT | GREEN(Blue green and Pale yellow) |
| Color | C48329 __ |
| FDA SPL set id | 662027 |
| Imprint code | Cipla10mg;382 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 76282-698 |